Sphenopalatine Ganglion Block and Radiofrequency Ablation: Technical Notes and Efficacy.
Conclusion: Targeting the SPG is a promising treatment option for refractory CHs. RFA and neuromodulation have the potential to offer long-term significant pain relief, but more randomized studies are needed to demonstrate their efficacy.
PMID: 30983899 [PubMed]
Source: Ochsner Journal - Category: General Medicine Tags: Ochsner J Source Type: research
More News: Anesthesia | Anesthesiology | Brain | Ganglions | General Medicine | Headache | Neurology | Pain | Study